BACKGROUND: The aim of this study was to investigate the epidemiology of oral yeast colonization and infection amongst cancer patients. METHODS: Patients with solid tumor, head-neck cancer or hematological malignancy were recruited into the study. Demographic data on age, gender, type of cancer, preceding treatment with antibiotics, anti-fungal agents, chemotherapy, radiation or surgery and presence of dentures were recorded on admission. Oral examination and microbial swabs were obtained and yeast culture, identification and antifungal susceptibility performed. RESULTS: Oral yeast colonization was prevalent in 56.8% (227/400) of all cancer patients and 18.9% (43/227) of those had clinical and microbiological evidence of infection. The incidence of oral candidiasis in yeast colonized patients was highest in head neck cancer (29.2%) followed by hematological malignancies (20.5%) and solid tumor (17%) patients. Age and dentures were identified as independent risk factors associated with yeast carriage. Candida albicans was the dominant (74%) species (497.5 per 1000 cancer admissions) followed by C. glabrata (11.5%), C. tropicalis (2.6%), C. krusei (2.6%) and C. parapsilosis (1.9%). The overall resistance to azoles was 28.2% (75/266). Resistance to specific drugs was seen for fluconazole (4.5%), itraconazole (11.7%), ketoconazole (11.3%), voriconazole (0.75%) and caspofungin (41.1%) but none to amphotericin B or nystatin. CONCLUSIONS: The highest incidence of oral candidiasis amongst cancer patients was seen in head neck cancers. The majority of infections were caused by C. albicans but almost one third of patients harbored non-C. albicans strains such as C. glabrata which were often more resistant to anti-fungal agents.
BACKGROUND: The aim of this study was to investigate the epidemiology of oral yeast colonization and infection amongst cancerpatients. METHODS:Patients with solid tumor, head-neck cancer or hematological malignancy were recruited into the study. Demographic data on age, gender, type of cancer, preceding treatment with antibiotics, anti-fungal agents, chemotherapy, radiation or surgery and presence of dentures were recorded on admission. Oral examination and microbial swabs were obtained and yeast culture, identification and antifungal susceptibility performed. RESULTS: Oral yeast colonization was prevalent in 56.8% (227/400) of all cancerpatients and 18.9% (43/227) of those had clinical and microbiological evidence of infection. The incidence of oral candidiasis in yeast colonized patients was highest in head neck cancer (29.2%) followed by hematological malignancies (20.5%) and solid tumor (17%) patients. Age and dentures were identified as independent risk factors associated with yeast carriage. Candida albicans was the dominant (74%) species (497.5 per 1000 cancer admissions) followed by C. glabrata (11.5%), C. tropicalis (2.6%), C. krusei (2.6%) and C. parapsilosis (1.9%). The overall resistance to azoles was 28.2% (75/266). Resistance to specific drugs was seen for fluconazole (4.5%), itraconazole (11.7%), ketoconazole (11.3%), voriconazole (0.75%) and caspofungin (41.1%) but none to amphotericin B or nystatin. CONCLUSIONS: The highest incidence of oral candidiasis amongst cancerpatients was seen in head neck cancers. The majority of infections were caused by C. albicans but almost one third of patients harbored non-C. albicans strains such as C. glabrata which were often more resistant to anti-fungal agents.
Authors: J C Junqueira; A O C Jorge; J O Barbosa; R D Rossoni; S F G Vilela; A C B P Costa; F L Primo; J M Gonçalves; A C Tedesco; J M A H Suleiman Journal: Lasers Med Sci Date: 2012-01-26 Impact factor: 3.161
Authors: Devon L Allison; Nina Scheres; Bastiaan P Krom; Mark E Shirtliff; Hubertine M E Willems; Carolien S Bode Journal: Infect Immun Date: 2019-10-18 Impact factor: 3.441
Authors: Ana Mañas; Laura Cerezo; Alejandro de la Torre; Mariola García; Héctor Alburquerque; Blanca Ludeña; Ana Ruiz; Ana Pérez; Ana Escribano; Aurea Manso; Luis Alberto Glaria Journal: Clin Transl Oncol Date: 2012-09-08 Impact factor: 3.405
Authors: N Pieralisi; P de Souza Bonfim-Mendonça; M Negri; I C Jarros; T Svidzinski Journal: Eur J Clin Microbiol Infect Dis Date: 2016-06-01 Impact factor: 3.267
Authors: Simon F Dufresne; Kieren A Marr; Emily Sydnor; Janet F Staab; Judith E Karp; Kit Lu; Sean X Zhang; Christian Lavallée; Trish M Perl; Dionysios Neofytos Journal: J Clin Microbiol Date: 2014-03-12 Impact factor: 5.948
Authors: Fernanda Freire; Cleber Ferraresi; Antonio Olavo C Jorge; Michael R Hamblin Journal: J Photochem Photobiol B Date: 2016-04-01 Impact factor: 6.252